乙胺和甲在急性心力衰竭患者中:最近试验的见解
Chukwuemeka A Umeh1,2,3, Tamanna Mohta1, Gagan Kaur1
1Department of Internal Medicine, Hemet Global Medical Center, Hemet, CA, USA.
Cardiology research
|April 22, 2024
概括
前期阿扎胺与循环利尿剂一起增加心力衰竭患者的尿路,特别是那些碳酸盐和GFR较高的患者. 酸性利尿剂也可以改善利尿症,但有功能障碍的风险.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 循环利尿剂是心力衰竭的标准,但可能会遇到阻力.
- 与其他利尿剂的前期组合治疗正在研究急性不补偿性心力衰竭 (ADHF).
研究的目的:
- 审查近期随机对照试验,关于在ADHF中提前使用乙醇胺和 thiazide 利尿剂.
- 在住院的ADHF患者中评估这些组合的疗效和安全性.
主要方法:
- 在ADHF中对乙醇胺进行两项随机对照试验的审查.
- 在ADHF中对 thiazide 利尿剂进行两项随机对照试验的综述.
- 对利尿反应,自然,减肥和功能进行分析.
主要成果:
- 乙胺增加了尿路和自然尿路,特别是在血清二碳酸盐≥27mmol/L和更高基线GFR的患者中.
- 甲酸增加了尿路和体重减轻,但增加了功能受损的风险.
- 前期阿扎胺可能有利于选定的ADHF患者,其双碳酸盐含量升高,功能良好.
- thiazide 利尿剂改善了利尿反应,但增加了脏风险,没有明确证据表明减少了住院时间.
结论:
- 在经过精心挑选的ADHF患者中,前期阿扎胺具有潜在的益处.
- 前期的化物利尿剂改善了利尿反应,但具有脏风险,并且在住院时间方面缺乏经过证明的益处.
- 基于二碳酸盐水平和功能的患者选择对于ADHF的前期利尿剂组合至关重要.
相关概念视频
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
620
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
620
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
531
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
531
01:26Heart Failure Drugs: Inotropic Agents
577
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
577
01:16Antihypertensive Drugs: Action of Diuretics
679
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
679